Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Developability assessment at early-stage discovery to enable development of antibody-derived therapeutics
Weijie Zhang, Hao Wang, Nan Feng, et al.
Antibody Therapeutics (2022) Vol. 6, Iss. 1, pp. 13-29
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Identifying developability risks for clinical progression of antibodies using high-throughput in vitro and in silico approaches
Tushar Jain, Todd Boland, Maximiliano Vásquez
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 31
Prospects for the computational humanization of antibodies and nanobodies
G. Gordon, Matthew I. J. Raybould, Chi Yan Wong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Reduction of monoclonal antibody viscosity using interpretable machine learning
Emily K. Makowski, Hsin-Ting Chen, Tiexin Wang, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 7
LAP: Liability Antibody Profiler by sequence & structural mapping of natural and therapeutic antibodies
Tadeusz Satława, Mateusz Tarkowski, Sonia Wróbel, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 3, pp. e1011881-e1011881
Open Access | Times Cited: 6
Biophysical cartography of the native and human-engineered antibody landscapes quantifies the plasticity of antibody developability
Habib Bashour, Eva Smorodina, Matteo Pariset, et al.
Communications Biology (2024) Vol. 7, Iss. 1
Open Access | Times Cited: 6
Biodegradable polymeric microsphere formulations of full-length anti-VEGF antibody bevacizumab for sustained intraocular delivery
Shwetha Iyer, Cameron C. Lee, Mansoor M. Amiji
Drug Delivery and Translational Research (2025)
Open Access
Trends and Challenges in Bispecific Antibody Production
Mikhail S. Karbyshev, Irina Kalashnikova, Veronika Dubrovskaya, et al.
Journal of Chromatography A (2025), pp. 465722-465722
Closed Access
Accelerating antibody discovery and design with artificial intelligence: Recent advances and prospects
Ganggang Bai, Chuance Sun, Ziang Guo, et al.
Seminars in Cancer Biology (2023) Vol. 95, pp. 13-24
Closed Access | Times Cited: 14
Nanobodies: a promising approach to treatment of viral diseases
Vitória Meneghetti Minatel, Carlos Roberto Prudêncio, Benedito Barraviera, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 4
Antibody complementarity-determining region design using AlphaFold2 and DDG predictor
Takafumi Ueki, Masahito Ohue
The Journal of Supercomputing (2024) Vol. 80, Iss. 9, pp. 11989-12002
Open Access | Times Cited: 2
Selection of bispecific antibodies with optimal developability using FcRn‑pH‑HPLC as an optimized FcRn affinity chromatography method
Thomas Müller, Carolin Tasser, Michael Tesar, et al.
mAbs (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Monoclonal Antibody Development for Cancer Treatment Using the Phage Display Library Platform
Tiantian Zhang, Zhe Wang
Biologics (2024) Vol. 4, Iss. 1, pp. 55-74
Open Access | Times Cited: 1
Leveraging bioanalytical characterization of fractionated monoclonal antibody pools to identify aggregation‐prone and less filterable proteoforms during virus filtration
Solomon Isu, Lilia Vinskus, Derek Silva, et al.
Biotechnology Progress (2024) Vol. 40, Iss. 4
Open Access | Times Cited: 1
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows
Tushar Jain, Bianka Prinz, Alexander Marker, et al.
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Engineering of pH-dependent antigen binding properties for toxin-targeting IgG1 antibodies using light-chain shuffling
Tulika Tulika, Fulgencio Ruso‐Julve, Shirin Ahmadi, et al.
Structure (2024) Vol. 32, Iss. 9, pp. 1404-1418.e7
Open Access | Times Cited: 1
Computational design of developable therapeutic antibodies: efficient traversal of binder landscapes and rescue of escape mutations
Frédéric A. Dreyer, Constantin Schneider, Aleksandr Kovaltsuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Towards the Application of a Label-Free Approach for Anti-CD47/PD-L1 Bispecific Antibody Discovery
A. S. Grevtsev, Alexandra D. Azarian, Aleksei K. Misorin, et al.
Biosensors (2023) Vol. 13, Iss. 12, pp. 1022-1022
Open Access | Times Cited: 3
Nano-differential scanning fluorimetry as a tool for the assessment of refolded antibody fragments: A case study for anti-Pfs25 single-chain antibodies
Harvinder Kour Khera, Ashwathi Valiyaparambil, Deepak K Jagannath, et al.
Biochemical Engineering Journal (2024) Vol. 206, pp. 109287-109287
Closed Access
Druggability properties of a L309K mutation in the antibody CH2 domain
Cui Li, Qingqing Yao, Jiang Li
3 Biotech (2024) Vol. 14, Iss. 6
Closed Access
A case study of a bispecific antibody manufacturability assessment and optimization during discovery stage and its implications
Shuang Wang, Weijie Zhang, Baotian Yang, et al.
Antibody Therapeutics (2024) Vol. 7, Iss. 3, pp. 189-198
Open Access
Use of Industrial Scale Chromatography in Pharmaceutical Discovery/Manufacturing
Gregory Gilmartin
Elsevier eBooks (2024)
Closed Access
AI-accelerated therapeutic antibody development: practical insights
Luca Santuari, Marianne Bachmann Salvy, Ioannis Xénarios, et al.
Frontiers in Drug Discovery (2024) Vol. 4
Open Access
Discovery of a common light chain bispecific antibody targeting PD-1 and PD-L1 by Hybridoma-to-phage-to-yeast (H2PtY) platform
Peipei Liu, Chunyin Gu, Xiaodan Cao, et al.
Antibody Therapeutics (2024) Vol. 8, Iss. 1, pp. 1-12
Open Access
Thermal and pH stress dictate distinct mechanisms of monoclonal antibody aggregation
Huan Meng, Kuin Tian Pang, Corrine Wan, et al.
International Journal of Biological Macromolecules (2024), pp. 136601-136601
Closed Access
Designing Robust Monoclonal Antibody Drug Products: Pitfalls of Simplistic Approaches for Stability Prediction
Kelvin B. Rembert, Yatin R. Gokarn, Atul Saluja
Journal of Pharmaceutical Sciences (2024) Vol. 113, Iss. 8, pp. 2296-2304
Closed Access
Page 1 - Next Page

Scroll to top